Streetbeat News

Stock Prices

CEVA

CEVA shares are trading higher following the announcement of their Q4 adjusted EPS results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:04 pm

AAPL

AMZN

GOOG

META

MSFT

NVDA

QQQ

SPY

TSLA

Nvidia (NVDA) is at the forefront of the AI revolution, with its stock surging 45.2% since a breakout on January 8, 2024, largely driving the stock market's performance this year. NVDA's upcoming earnings on February 21 are highly anticipated, with whisper numbers suggesting earnings of $5 and revenue of $22B, above consensus estimates. The stock's performance and earnings report are seen as pivotal for the near-term direction of the stock market. Early trade shows positive money flows in major tech stocks and ETFs, with aggressive buying in penny and junk stocks, and a shift of positive sentiment towards Bitcoin.

Portfolio Pulse from The Arora Report

February 14, 2024 | 4:03 pm

BLNK

Blink Charging Co (NASDAQ:BLNK) shares rose after announcing preliminary Q4 results, expecting revenue over $42 million and full-year 2023 revenue to exceed $140 million, surpassing previous guidance. The company also anticipates a positive adjusted EBITDA run rate by December 2024.

Portfolio Pulse from Adam Eckert

February 14, 2024 | 4:03 pm

EQT

EQT shares are trading lower following the announcement of their Q4 financial results, which did not meet expectations.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:03 pm

PRTA

Prothena Corp (NASDAQ:PRTA) is scheduled to release its quarterly earnings report on February 15, 2024, with an expected EPS of $-1.22. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, Prothena has had mixed earnings performance but has seen significant share price movements following earnings announcements. Currently, the stock is down 48.48% over the last 52 weeks, trading at $26.49 as of February 13.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 4:02 pm

RARE

Ultragenyx Pharmaceutical (NASDAQ:RARE) is scheduled to release its quarterly earnings report on February 15, 2024, with an estimated EPS of $-1.62. Analysts and investors will be closely watching for not only an earnings beat but also positive guidance for future growth. The company's past earnings performance shows a mix of misses and beats, with corresponding stock price movements. Shares have been trading at $43.98 as of February 13, showing a 2.78% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 4:02 pm

ALKS

Alkermes (NASDAQ:ALKS) is scheduled to release its quarterly earnings report on February 15, 2024, with analysts expecting an EPS of $0.51. The company's past performance shows a history of beating EPS estimates, leading to positive stock price movements. Shares are currently trading at $27.23, marking a 5.13% increase over the last 52 weeks. Investors are looking forward to not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 4:01 pm

CBRE

CBRE Group (NYSE:CBRE) is scheduled to release its quarterly earnings report on February 15, 2024, with an estimated EPS of $1.18. Analysts and investors are keen on whether CBRE will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price to past earnings reports, with a general downtrend in the share price over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 4:01 pm

CORT

Corcept Therapeutics (NASDAQ:CORT) is scheduled to release its quarterly earnings report on February 15, 2024, with an estimated EPS of $0.26. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price to past earnings performances, with the last quarter's beat followed by a 9.97% drop. Shares are currently trading at $23.05, up 4.48% over the last year.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 4:01 pm

BLNK

Blink Charging's stock price increased following the announcement of positive preliminary results for the fourth quarter.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:01 pm